BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-135@pharmaconomics
DTSTAMP:20260707T034542Z
DTSTART;VALUE=DATE:20261101
DTEND;VALUE=DATE:20261102
SUMMARY:ERAS Phase 2 — ERAS-007
DESCRIPTION:Phase 2 trial results for ERAS-007 in Advanced or Metastatic Solid Tumors are due Nov 1\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT04866134\n\nTrack it: https://www.pharmaconomics.com/e/135
URL:https://www.pharmaconomics.com/e/135
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ERAS catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR